Cambridge Investment Research Advisors, Inc. Amarin Corp Plcuk Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,342 shares of AMRN stock, worth $6,308. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,342
Previous 22,142
53.29%
Holding current value
$6,308
Previous $14,000
64.29%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AMRN
# of Institutions
181Shares Held
68.6MCall Options Held
192KPut Options Held
78.1K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$15.2 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$7.57 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$2.69 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.53 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.51 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $246M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...